{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:16:31Z","timestamp":1769213791510,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1986,1,1]],"date-time":"1986-01-01T00:00:00Z","timestamp":504921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1986]]},"DOI":"10.1007\/bf00614200","type":"journal-article","created":{"date-parts":[[2004,11,25]],"date-time":"2004-11-25T01:23:43Z","timestamp":1101345823000},"page":"79-82","source":"Crossref","is-referenced-by-count":27,"title":["The absorption of piretanide from the gastro-intestinal tract is site-dependent"],"prefix":"10.1007","volume":"30","author":[{"given":"D.","family":"Brockmeier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. -G.","family":"Grigoleit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Leonhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/BF00614003","volume":"9","author":"H Ochs","year":"1975","unstructured":"Ochs H, Bodem G, Sch\u00e4fer PK, Kodrat G, Dengler HJ (1975) Absorption of digoxin from the distal part of the intestine in man. Eur J Clin Pharmacol 9: 95?97","journal-title":"Eur J Clin Pharmacol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF00613427","volume":"9","author":"KE Andersson","year":"1975","unstructured":"Andersson KE, Nyberg L, Dencker H, G\u00f6thlin J (1975) Absorption of digoxin in man after oral and intrasigmoid administration studied by portal vein catheterization. Eur J Clin Pharmacol 9: 39?47","journal-title":"Eur J Clin Pharmacol"},{"key":"CR3","first-page":"14","volume":"10","author":"BH Meyer","year":"1982","unstructured":"Meyer BH, M\u00fcller FO, Grigoleit H-G, Heptner W (1982) Endoscopic placement in volunteers to investigate site of absorption of piretanide: Preliminary report. IRCS Med Sci 10: 14","journal-title":"IRCS Med Sci"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00544017","volume":"25","author":"U Gundert-Remy","year":"1983","unstructured":"Gundert-Remy U, Hildebrandt R, Stiehl A, Weber E, Zurcher G, Da Prada M (1983) Intestinal absorption of levodopa in man. Eur J Clin Pharmacol 25: 69?72","journal-title":"Eur J Clin Pharmacol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF00542170","volume":"27","author":"E Lunell","year":"1984","unstructured":"Lunell E, Andersson K-E, Borg\u00e5 O, Fagerstr\u00f6m P-O, Johannesson N, Kjellin G, Persson CGA, Sj\u00f6lund K (1984) Absorption of enprofylline from the gastrointestinal tract in healthy subjects. Eur J Clin Pharmacol 27: 329?333","journal-title":"Eur J Clin Pharmacol"},{"issue":"I","key":"CR6","first-page":"760","volume":"35","author":"O Schuster","year":"1985","unstructured":"Schuster O, Hartel M, Hagemann B, Gikalov I, Schiemann O, Fenner H (1985) Untersuchungen zur klinischen Pharmakokinetik von Allopurinol Arzneimittelforsch\/Drug-Res 35 [I]: 760?765","journal-title":"Untersuchungen zur klinischen Pharmakokinetik von Allopurinol Arzneimittelforsch\/Drug-Res"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00547421","volume":"29","author":"D Brockmeier","year":"1985","unstructured":"Brockmeier D, Grigoleit H-G, Leonhardt H (1985) Absorption of glibenclamide from different sites of the gastro-intestinal tract. Eur J Clin Pharmacol 29: 193?197","journal-title":"Eur J Clin Pharmacol"},{"issue":"II","key":"CR8","first-page":"1273","volume":"33","author":"E Klaus","year":"1983","unstructured":"Klaus E, Alpermann HG, Caspritz W, Linz W, Sch\u00f6lkens B (1983) Vascular effects of piretanide. Arzneimittelforsch\/Drug-Res 33 [II]: 1273?1276","journal-title":"Arzneimittelforsch\/Drug-Res"},{"key":"CR9","first-page":"399","volume":"11","author":"W Merkel","year":"1976","unstructured":"Merkel W, Bormann D, Mania D, Muschaweck R, Hropot M (1976) Piretanide (HOE 118) a new high ceiling salidiuretic. Eur J Med Chem 11: 399?406","journal-title":"Eur J Med Chem"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/01971528408062996","volume":"5","author":"W Heptner","year":"1984","unstructured":"Heptner W, Baudner S, Dagrosa EE, Hellstern C, Irmisch R, Strecker H, Wissmann H (1984) A radioimmunoassay to measure piretanide in human serum and urine. J Immunoassay 5: 13?27","journal-title":"J Immunoassay"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/BF01488743","volume":"34","author":"FH Dost","year":"1958","unstructured":"Dost FH (1958) \u00dcber ein einfaches statistisches Dosis-Umsatz-Gesetz. Klin Wochenschr 34: 655?657","journal-title":"Klin Wochenschr"},{"key":"CR12","first-page":"315","volume-title":"A concept for the assessment of bioavailability in complex systems in terms of amounts and rates","author":"HM Hattingberg von","year":"1982","unstructured":"von Hattingberg HM, Brockmeier D (1982) A concept for the assessment of bioavailability in complex systems in terms of amounts and rates. In: Bozler G, van Rossum JM (eds) Titisee Conference Pharmacokinetics during Drug Development: Data analysis and evaluation techniques. Oct. 1978. Gustav Fischer, Stuttgart, pp 315?323"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-3-663-14027-6_13","volume-title":"Methods in clinical pharmacology","author":"HM Hattingberg von","year":"1980","unstructured":"von Hattingberg HM, Brockmeier D, Voegele D (1980) A method for in vivo ? in vitro correlation using the additivity of mean times in biopharmaceutical models. In: Rietbrock N, Woodcock BG, Neuhaus G (eds) Methods in clinical pharmacology. Vieweg, Braunschweig Wiesbaden, pp 85?93"},{"issue":"II","key":"CR14","first-page":"1604","volume":"34","author":"D Brockmeier","year":"1984","unstructured":"Brockmeier D (1984) In vitro ? in vivo correlation, a time scaling problem? Evaluation of mean times. Arzneimittelforsch\/Drug-Res 34 [II]: 1604?1607","journal-title":"Arzneimittelforsch\/Drug-Res"},{"key":"CR15","first-page":"413","volume-title":"Verteilungsfreie Methoden in der Biostatistik","author":"GA Lienert","year":"1973","unstructured":"Lienert GA (1973) Verteilungsfreie Methoden in der Biostatistik. Verlag Anton Hain, Meisenheim am Glan, pp 413?428"},{"issue":"2","key":"CR16","first-page":"62","volume":"12","author":"R Heller","year":"1981","unstructured":"Heller R (1981) Ein FORTRAN-Programm zur Berechnung exakter P-Werte f\u00fcr Fisher-Pitman-Randomisierungstest. EDV Med Biol 12 [2]: 62?64","journal-title":"EDV Med Biol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.2042-7158.1957.tb12289.x","volume":"9","author":"BB Brodie","year":"1957","unstructured":"Brodie BB, Hogben CAM (1957) Some physico-chemical factors in drug action. J Pharm Pharmacol 9: 345?380","journal-title":"J Pharm Pharmacol"},{"key":"CR18","first-page":"361","volume":"119","author":"PA Shore","year":"1957","unstructured":"Shore PA, Brodie BB, Hogben CAM (1957) The gastric secretion of drugs: a pH partition hypothesis. J Pharmacol Exp Ther 119: 361?369","journal-title":"J Pharmacol Exp Ther"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3109\/00365528209181117","volume":"17","author":"W Kruis","year":"1982","unstructured":"Kruis W, B\u00fcll U, Eisenburg J, Paumgartner G (1982) Retrograde colonic spread of sulphasalazine enemas. Scand J Gastroenterol 17: 933?938","journal-title":"Scand J Gastroenterol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5173(84)90101-7","volume":"18","author":"CG Wilson","year":"1984","unstructured":"Wilson CG, Parr GD, Kennerley JW, Taylor MJ, Davis SS, Hardy JG, Rees JA (1984) Pharmacokinetics and in vivo scintigraphic monitoring of a sustained release acetylsalicylic acid formulation. Int J Pharm 18: 1?8","journal-title":"Int J Pharm"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00614200.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00614200\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00614200","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T23:42:57Z","timestamp":1554421377000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00614200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1986]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1986]]}},"alternative-id":["BF00614200"],"URL":"https:\/\/doi.org\/10.1007\/bf00614200","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1986]]}}}